Autoimmune Diseases News
🇺🇸 FDAFDA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–7 of 7 articles
The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities in 2024
UCB Acquires Antibody Treatment Maker: Implications for Autoimmune Disease Market
InnoCare Pharma Begins Phase III Trial of Orelabrutinib for Systemic Lupus Erythematosus Treatment
ACRP 2026: Immunology Clinical Research Trends to Watch
Nkarta Receives FDA Approval for Outpatient NKX019 Dosing in Autoimmune Disease Treatment
FDA Approves Litfulo: Key Facts on Pfizer’s Alopecia Treatment
FDA Approves First Interchangeable Humira Biosimilar: Key Details